SEC Form 4 · accession 0000899243-17-003497
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Andrew Hurley
Officer — Chief Commercial Officer
Period of report
Jan 31, 2017
Accepted (ET)
Feb 10, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.56 | Jan 31, 2017 | A | 60,000 | A | — | Jan 30, 2027 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.